NIH Director's New Innovator Award

Stitching the Future: Brother International Corporation Announces New Innovation for 2023 Sewing, Embroidery and Quilting Machines Exclusive to Brother Authorized Dealers

Retrieved on: 
Monday, August 14, 2023

BRIDGEWATER, N.J., Aug. 14, 2023 /PRNewswire/ -- Today, Brother International Corporation announced its latest product additions for Brother Authorized Dealers featuring technological advances across the printing, sewing, embroidery and quilting machines for 2023, including the first ever Fabric Printer. PrintModa Studio Fabric Printer is powered by Brother Artspira, a mobile app enabling a new level of connected creativity. With the introduction of five new machines with a range of capabilities and complementary accessories, Brother continues its commitment to introducing best-in-class products that demonstrate innovation and the industry's latest technology, driven through connection and creativity.

Key Points: 
  • PrintModa Studio Fabric Printer is powered by Brother Artspira, a mobile app enabling a new level of connected creativity.
  • From software and luggage to sewing feet and thread kits, Brother Genuine Accessories are the ideal complement to your Brother machines.
  • Simply connect PrintModa to a Brother wireless enabled sewing or embroidery machine or ScanNCut DX machine to add additional dimension to projects.
  • To learn more about the full line up of new Brother machines or locate a Brother Authorized Dealer near you, please visit Brother-usa.com/Brother-Experience .

Artera Welcomes New Leaders as Part of Its Commitment to Customer Success and Innovation

Retrieved on: 
Thursday, April 13, 2023

SANTA BARBARA, Calif., April 13, 2023 /PRNewswire/ -- Artera (formerly WELL Health), a SaaS digital health leader in patient communications, recently welcomed Karri Alexion-Tiernan as VP of Product Marketing, Joanne Chen as VP of Data and Mark Thomson as VP of Customer Success. Alexion-Tiernan and Chen are seasoned leaders who will drive the company's continued growth and data strategy as part of its Innovation Organization. Thomson will advance the Customer Experience team's commitment to customer success and personalized service.

Key Points: 
  • Alexion-Tiernan and Chen are seasoned leaders who will drive the company's continued growth and data strategy as part of its Innovation Organization.
  • Thomson will advance the Customer Experience team's commitment to customer success and personalized service.
  • "Artera is proud to welcome two experienced leaders to our Innovation Organization," said Isabelle Meyer Stapf, SVP of Product at Artera.
  • As VP of Customer Success at Artera, Thomson will oversee the Customer Success team with the ongoing delivery of a high-quality  customer experience and help customers maximize the value of Artera to achieve their business objectives.

GeoVax Appoints Jayne Morgan, M.D., to its Board of Directors

Retrieved on: 
Wednesday, December 7, 2022

ATLANTA, GA, Dec. 07, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, announced today that it has appointed Jayne Morgan, M.D., to its Board of Directors.

Key Points: 
  • Morgan has spearheaded effective outreach initiatives that have greatly influenced and improved public health education and sentiment in target communities, particularly regarding COVID-19,” said David Dodd, Chairman and CEO of GeoVax.
  • Dr. Morgan holds several board positions with the American Heart Association (AHA) including Board Member of its Atlanta Chapter, Board Member of the National Diversity and Inclusion team, National Board Member of the technology team and Regional Board Member of the AHA Health Equity Committee.
  • GeoVax Labs, Inc. is a clinical-stage biotechnology company developing novel therapies and vaccines for cancers and many of the world’s most threatening infectious diseases.
  • GeoVax has a leadership team who have driven significant value creation across multiple life science companies over the past several decades.

EpiVario Appoints New Scientific Advisory Board Members and Expands Operations

Retrieved on: 
Tuesday, October 11, 2022

PHILADELPHIA, Oct. 11, 2022 /PRNewswire/ -- EpiVario, a biotech company developing novel therapeutics for memory-related psychiatric disorders, today announced that Anthony Ford-Hutchinson, PhD, and Paul Kenny, PhD, have been appointed to the Company's Scientific Advisory Board (SAB). They each bring deep industry and scientific experience that will help further guide EpiVario on the translation of its core discoveries through research into development, and future commercialization.

Key Points: 
  • "We are thrilled to welcome Dr. Ford-Hutchinson and Dr. Kenny to our Scientific Advisory Board," said Thomas Kim, President and CEO of EpiVario.
  • Currently, he serves as a board member or scientific advisor to various startup companies, corporations, and private foundations.
  • "I am excited to join EpiVario's Scientific Advisory Board, to help drive translation and development of its exciting pipeline that may offer new therapeutic options to patients in need."
  • Along with the new appointments to its SAB, EpiVario is expanding its operations having secured additional funding from angel investors.

Immunitas Therapeutics to Present Preclinical Data on IMT-009 at the 2022 Society for Immunotherapy of Cancer (SITC) Annual Meeting

Retrieved on: 
Wednesday, October 5, 2022

WALTHAM, Mass., Oct. 5, 2022 /PRNewswire/ -- Immunitas Therapeutics ("Immunitas"), a precision immunotherapy company committed to discovering and developing novel, differentiated therapeutics for patients with cancer, today announced they will present preclinical data on lead program IMT-009, a fully human monoclonal antibody against a novel immuno-oncology target CD161, at the Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting, held both virtually and in Boston from November 8-12, 2022. The company also announced the addition of Juliana Idoyaga, Ph.D., to its Scientific Advisory Board.

Key Points: 
  • The SITC presentation will demonstrate the potential of IMT-009 as a novel cancer immunotherapy to treat solid tumors and hematological malignancies.
  • Poster Presentation Details for IMT-009:
    Date/Time:All poster presentations are made available by the conference on November 10, 2022.
  • The SITC poster presentation will be available on the Immunitas Therapeutics website on November 10, 2022.
  • Immunitas is a precision immunotherapy company committed to discovering and developing novel, differentiated treatments for patients with cancer.

Guidehouse Ranked 2nd-Largest Healthcare Management Consulting Firm by Modern Healthcare

Retrieved on: 
Wednesday, August 17, 2022

WASHINGTON, Aug. 17, 2022 /PRNewswire/ -- Guidehouse, a leading global provider of consulting and outsourcing services to public sector and commercial clients, has been ranked 2022's second-largest healthcare management consulting firm by Modern Healthcare.

Key Points: 
  • WASHINGTON, Aug. 17, 2022 /PRNewswire/ -- Guidehouse, a leading global provider of consulting and outsourcing services to public sector and commercial clients, has been ranked 2022's second-largest healthcare management consulting firm by Modern Healthcare.
  • 3 last year, Guidehouse is ranked among 29 US companies based on total 2021 healthcare revenue.
  • Continually growing, Guidehouse has been ranked among the top six companies on the annual list 10 times.
  • Guidehouse is a leading global provider of consulting services to the public sector and commercial markets, with broad capabilities in management, technology, and risk consulting.

Shimifrez Inc. (www.shimifrez.com), a Global Leader in Fabricating Precision Sheet Metal Parts Chemically Etched and Electroformed Metal Components Obtains ISO 13485 Medical Device Manufacturing Certification

Retrieved on: 
Monday, May 23, 2022

This support begins with initial concepts, proceeds through optimizing topology, optimum materials & finishes, electrical & mechanical testing, and finishes with complete in-house manufacturing in our Canadian facility.

Key Points: 
  • This support begins with initial concepts, proceeds through optimizing topology, optimum materials & finishes, electrical & mechanical testing, and finishes with complete in-house manufacturing in our Canadian facility.
  • Precision photochemical milling is a cost effective method for producing complex flat sheet metal and 3D metal parts for prototyping and quantity production.
  • Shimifrez offers a rapid-response service to deliver micro components to several precision industries such as the aerospace/satellite , Medical , Automotive , Telecommunications and micro- electronics sectors .
  • Whether you are in the medical device manufacturer or aerospace or micro-electronics or telecommunications, we have the capabilities to help.

Throwing Drug Resistance for a Loop

Retrieved on: 
Thursday, May 12, 2022

SAN FRANCISCO, May 12, 2022 /PRNewswire/ -- Viruses in the herpesvirus family are leading causes of birth defects, blindness, and failed organ transplants worldwide. Antiviral drugs can combat these viruses, but patients often develop resistance to the drugs—rendering them ineffective.

Key Points: 
  • Antiviral drugs can combat these viruses, but patients often develop resistance to the drugsrendering them ineffective.
  • "This study shows, for the first time, that feedback circuits can be a drug target to treat viruses.
  • "Antiviral drug resistance is a huge problem that affects millions of people around the world," says Chaturvedi, first author of the new study and research investigator at Gladstone.
  • The scientists realized that if they could develop a drug to disrupt this loop, they could potentially treat CMV infection while avoiding drug resistance.

Open4Sale Technology Ushers in the Future of Retail During Interactive Live Video and Live-Streaming Customer Experience

Retrieved on: 
Thursday, February 10, 2022

Online retail store sites are static and incredibly limited in providing a personalized shopping experience to customers, which results in an extraordinary loss of sales, said Simon La Barrie, CEO and founder of Open4Sale Technology.

Key Points: 
  • Online retail store sites are static and incredibly limited in providing a personalized shopping experience to customers, which results in an extraordinary loss of sales, said Simon La Barrie, CEO and founder of Open4Sale Technology.
  • When you bring together video, live interaction, and integrated payment technology in one screen customers can see products, ask sales associates questions, and feel much more confident to make purchases.
  • Plus, I can shop anywhere in the world, including stores in China, where Im from, which only adds to the personalized experience.
  • O4S Techs app merges online and in-store shopping experiences by combining live chat, video, streaming, and instant payments that integrate to existing retail POS and e-commerce back-end systems.

Guidehouse Wins Best in KLAS® Award for Strategy, Growth, and Consolidation Consulting for 3rd Consecutive Year

Retrieved on: 
Tuesday, February 8, 2022

Now a 12-time Best in KLAS award winner, Guidehouse has a track record of consistently achieving one of the highest average firm scores each year.

Key Points: 
  • Now a 12-time Best in KLAS award winner, Guidehouse has a track record of consistently achieving one of the highest average firm scores each year.
  • According to a health system chief operating officer (COO) interviewed by KLAS, "Guidehouse is fantastic.
  • We didn't have a typical consulting engagement because Guidehouse sent people who knew how to partner with us.
  • Guidehouse is a leading global provider of consulting services to the public sector and commercial markets, with broad capabilities in management, technology, and risk consulting.